Summary
This 8-K filing from WellPoint, Inc. (the former name of Elevance Health) on February 22, 2013, primarily announces a key leadership transition. The Board of Directors elected Joseph R. Swedish as a Director, effective March 25, 2013, and appointed him to the Executive Committee of the Board. This appointment precedes his upcoming role as Chief Executive Officer, also effective March 25, 2013, as previously detailed in an offer letter. Investors should note that Mr. Swedish's election to the Board and the Executive Committee are in anticipation of his CEO role, ensuring a smooth leadership change. His compensation will be governed by his offer letter, and he will not participate in the company's standard director compensation program. The filing also confirms no disclosable relationships between Mr. Swedish and the company under SEC regulations.
Key Highlights
- 1Joseph R. Swedish elected as a Director of WellPoint, Inc., effective March 25, 2013.
- 2Mr. Swedish appointed to the Executive Committee of the Board of Directors.
- 3This Board appointment is in preparation for his role as Chief Executive Officer, commencing March 25, 2013.
- 4Mr. Swedish's compensation will be based on his offer letter dated February 6, 2013.
- 5As an executive officer, Mr. Swedish will not receive the company's director compensation.
- 6No Item 404(a) disclosable relationships exist between Mr. Swedish and the Company.
- 7The filing is dated February 22, 2013, with the earliest event reported on February 20, 2013.